Abstract Book of the ESMO 25th World Congress on Gastrointestinal Cancer 2023, Barcelona, Spain, 28 June - 1 July 2023 Last update June 2023 Abstract Book of the ESMO Asia Congress 2022 2-4 December 2022. Last update November 2022 Molecular Analysis for Precision Oncology Congress 2022 14-16 ...
期刊名称 Annals of OncologyANN ONCOL 期刊ISSN 0923-7534 期刊官方网站 https://www.sciencedirect.com/journal/annals-of-oncology 是否OA No 出版商 Elsevier Ltd 出版周期 Monthly 文章处理费 登录后查看 始发年份 1990 年文章数 72 影响因子 56.7(2023) scijournal影响因子 greensci影响因子中科院...
肿瘤学年鉴(Annals Of Oncology)是一本由Oxford University Press出版的一本医学-肿瘤学学术刊物,主要报道医学-肿瘤学相关领域研究成果与实践。本刊已入选来源期刊,属于国际一流期刊。该刊创刊于1990年,出版周期Monthly。2021-2022年最新版WOS分区等级:Q1,2023年发布的影响因子为56.7,CiteScore指数63.9,SJR指数13.942。
3.4 (2023) 5-year Journal Impact Factor 4.0 (2023) Downloads 2,200,463 (2023) Call for papers Collection Heroes and Legends in Surgical Oncology Series: Legacies and Lessons In the ever-evolving landscape of surgery, where advancements occur at an astonishing pace, it is crucial to remember...
Annals of Hematology & Oncology is an open access, peer reviewed, scholarly journal dedicated to publish articles in all areas of Hematology & Oncology.
What has prevented Annals of Oncology from reaching an impact factor of 6? (editorial) F Cavalli - 《Annals of Oncology Official Journal of the European Society for Medical Oncology》 被引量: 0发表: 1999年 Scaling up cancer diagnosis and treatment in developing countries: what can we learn ...
期刊名称:《Annals of Oncology》 | 2011年第1期 56.First-line chemotherapy for malignant peripheral nerve sheath tumor (MPNST) versus other histological soft tissue sarcoman subtypes and as a prognostic factor for MPNST: an EORTC Soft Tissue and Bone Sarcoma Group study 机译:一线化疗治疗恶性周围神...
- Transfusion medicine - Pediatric hematology - Supportive care Editor-in-Chief Massimo Breccia Journal Impact Factor 3.0 (2023) 5-year Journal Impact Factor 3.1 (2023) Submission to first decision (median) 9 days Downloads 974,155 (2023)...
Oct 23, 2023 0 0 Oncology & Cancer Immunotherapy shows promise as a kinder first-line treatment for advanced head and neck cancers Immunotherapy can extend the response of some head and neck tumors to treatment, maintaining the anti-tumor effects and preventing them from growing or spreading fo...
documents published in that journal. The chart shows the evolution of the average number of times documents published in a journal in the past two, three and four years have been cited in the current year. The two years line is equivalent to journal impact factor ™ (Thomson Reuters) ...